Aviva, Phoenix, EY and Google are among more than 60 large businesses taking part in a trial that aims to establish the best ways to cut sickness absence and improve return-to-work rates
The transaction underscores Inviga's commitment to supporting world-class, AI-driven diagnostic solutions conceived and built in India for global scale
Do iodine supplements cure thyroid problems? Does thyroid always cause weight gain? In this episode of our fact-check series, doctors debunk common thyroid myths
Max Healthcare's ₹6,000 crore plan to add 10,000 beds over four years will be fully funded through internal accruals, says CMD Abhay Soi, outlining a strategy for growth without margin dilution
Grant Thornton Bharat says India's pharma and healthcare sectors saw renewed investor confidence, driven by consolidation across pharma, biotech, and hospital segments
A Somali hospital ward packed with gasping children shows how war, climate and mistrust of vaccines is fueling the disease's return
Green means trace amounts present. Yellow would indicate a moderate amount. Orange and red are danger indicators. My grandfather's insulin dose was titrated
The facility, funded through ICICI Bank's CSR arm, will house advanced radiation equipment and serve thousands of cancer patients annually at Tata Memorial's Navi Mumbai campus
The Delhi High Court emphasised that the Consumer Protection Act must be construed liberally: it permits a remote-degree legal heir or any family member to file a complaint
Around 83 per cent of patients in India seek objective, accessible information to guide their healthcare choices, and nearly 90 per cent are willing to pay more for certified quality, as per a report by FICCI and EY-Parthenon. While India's healthcare efficiency outperforms global peers, structural and financial pressures reinforce the need for a national framework that sets clear minimum quality standards, enabling patients to make informed healthcare choices, the report, titled 'True Accountable Care: Maximizing Healthcare Delivery Impact, Efficiently', stated. The report, based on research across 250 hospitals in 40 cities with 75,000 beds, surveys of over 1,000 patients and 100-plus clinicians, consultation with CXOs and investors, stated that bed per capita capacity has doubled since 2000 in India. The country still has one of the lowest hospital bed densities globally and a dual payor-provider fragmentation challenge with just 25-30 beds per hospital compared to over 100 ...
Is charcoal toothpaste safe? Can oil pulling replace brushing? In this episode of our fact-check episode, dentists debunk the most common dental health myths and reveal what truly protects your smile.
UST works with third-party administrator (TPA) technology platforms, positioning the company to lead large-scale transformations for health insurers seeking agility and speed
Members of the Democratic party want a short extension of funding so they can also push for healthcare tax breaks that keep insurance costs lower for 24 million US citizens
Healthy Mode, featuring an AI-powered Healthy Score, seeks to help users make better food choices, focusing on nutrition
Over the past decade, India's cardiovascular device market has grown into a significant health-tech segment with an estimated value of $1.55 bn and projected to reach $2.34 bn by 2030
The Trump administration has announced a $100,000 annual H-1B visa fee hike; visa quotas remain unchanged at 65,000 for regular applicants and 20,000 for advanced degree holders
A rapid reform to healthcare systems, public policy and attitude in society would be required to address burden of Alzheimer's disease in population, even as medications and blood tests present a potential in diagnosis and treatment, researchers say in a Lancet Series. Alzheimer's disease -- the most common form of dementia -- is an ageing-related neurological disorder which steadily impacts one's memory and thought processes, eventually interfering with daily activities. Describing new treatments and diagnostic methods for the condition in a series of three papers in The Lancet journal, the international team of researchers said that medications -- lecanemab and donanemab -- could slow down Alzheimer's disease from advancing. The drugs, which target specific proteins in a cell, have shown an efficacy comparable to that of drugs for cancer and autoimmune disorders such as rheumatoid arthritis and multiple sclerosis, the team said. They added that however, high costs of medicines, .
Alkem Laboratories on Monday said it has launched a biosimilar product in India for the treatment of breast cancer. The company has introduced Pertuza injection 420mg/14mL, a pertuzumab biosimilar, for the treatment of HER2-positive breast cancer, the drug firm said in a statement. Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab, it added. "Oncology is a priority area for Alkem, and our efforts are focused on developing treatment options that combine scientific excellence with wider access. The launch of Pertuza reflects this commitment and further strengthens our oncology portfolio," Alkem CEO Vikas Gupta said. Shares of the company on Monday ended 0.69 per cent down at Rs 5,496 apiece on BSE.
The Association of Healthcare Providers of India (AHPI) and the Star Health and Allied Insurance Company on Sunday said they have mutually decided to restore cashless services at AHPI member hospitals effective October 10. It was also agreed that the parties will make all efforts to ensure that the other outstanding issues, including tariff revisions, are resolved by October 31, a joint statement said. To prevent similar incidents in future and to protect customer interests, the AHPI will help form a group of industry leaders who will collaborate with the key insurers to reach an industry-level agreement, it said. This decision has been taken in the interest of the patients and the policyholders to ensure that they continue to receive timely, hassle-free access to healthcare services without financial distress, it added.
Prime Minister Narendra Modi will be in Gujarat on February 24 and 25 and will launch a slew of development projects worth over Rs 52,250 crore related to health, road, rail, energy and tourism across the country. In a significant step towards strengthening tertiary healthcare in the country, the Prime Minister's Office (PMO) said, Modi will inaugurate five All India Institute of Medical Sciences (AIIMS) in Rajkot (Gujarat), Bathinda (Punjab), Raebareli (Uttar Pradesh), Kalyani (West Bengal) and Mangalagiri (Andhra Pradesh). He will inaugurate these facilities at a public function in Rajkot. At a function in Dwarka, the prime minister will inaugurate the 'Sudarshan Setu' connecting the Okha mainland and the Beyt Dwarka island built at a cost of around Rs 980 crore. The 2.32 km-long cable-stayed bridge is the longest of its kind in the country, the PMO said in a statement. Sudarshan Setu boasts a unique design, featuring a footpath adorned with verses from the Bhagavad Gita and imag